D. Boral Capital analyst Jesse Sobelson downgraded MicroVision to Hold from Buy without a price target. The company's Q4 results reinforce the growing concern around its limited visibility on near-term revenue while its operating losses and cash burn remain elevated, the analyst tells investors in a research note. The firm says MicroVision's financial results show that meaningful commercialization remains elusive.
